BSE filing, NSE: PERSISTENT. Summary written from the filing by ALFA Finder's alert engine.
Persistent Systems Ltd: key numbers
- Share price
- ₹5,848.00
- Market cap
- ₹96,980 Cr
- Revenue (annual)
- ₹14,748 Cr
- Net profit (annual)
- ₹1,865 Cr
- P/E (TTM)
- 53.8×Sector 22.9×
- Promoter holding
- 30.29%+0.00% QoQ
- FII holding
- 20.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Persistent Systems Ltd
All →Persistent Systems Investor Presentation: Key Takeaways
Q2 FY27: USD revenue $487.6M, +20% YoY (+30.3% INR). Operating PAT Rs4,951.5M, +5% YoY; reported PAT Rs3,515.1M, -25.4% on Nagarro costs. Nagarro acquisition pending.
Persistent Systems Credit Rating
Persistent Systems received credit ratings from ICRA for its proposed Commercial Paper and Non-Convertible Debentures totaling ₹8,000 Crore.
- Value
- ₹8,000 Cr
Persistent Systems Fund Raise of ₹4,265 Cr
Persistent Systems' board approved a Qualified Institutional Placement (QIP) of equity shares, aiming to raise up to ₹4,264.61 Crore.
- Value
- ₹4,265 Cr
Persistent Systems Credit Rating
Persistent Systems received a 'CRISIL AA+; Rating Watch with Developing Implications' rating for its proposed Rs. 7,000 Crore Non-Convertible Debentures from CRISIL Ratings.
- Value
- ₹7,000 Cr
Persistent Systems Preferential Issue
Persistent Systems Ltd has clarified the floor price for its equity issue, set at ₹5,761.00 per share.
Persistent Systems Capital Structure Change
Persistent Systems opened its QIP issue with a floor price of Rs. 5,550 per share. The issue aims to raise up to Rs. 4,264.61 Crore.
- Value
- ₹4,265 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date